STAVZOR - 68968-3125-1 - (valproic acid)

Alphabetical Index


Drug Information of STAVZOR

Product NDC: 68968-3125
Proprietary Name: STAVZOR
Non Proprietary Name: valproic acid
Active Ingredient(s): 125    mg/1 & nbsp;   valproic acid
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of STAVZOR

Product NDC: 68968-3125
Labeler Name: Noven Therapeutics, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022152
Marketing Category: NDA
Start Marketing Date: 20080801

Package Information of STAVZOR

Package NDC: 68968-3125-1
Package Description: 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3125-1)

NDC Information of STAVZOR

NDC Code 68968-3125-1
Proprietary Name STAVZOR
Package Description 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3125-1)
Product NDC 68968-3125
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name valproic acid
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20080801
Marketing Category Name NDA
Labeler Name Noven Therapeutics, LLC
Substance Name VALPROIC ACID
Strength Number 125
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]

Complete Information of STAVZOR


General Information